Sodium thiosulfate does not reduce heart damage after a heart attack
Sodium thiosulfate showed no benefits for reducing injury to damaged areas of heart muscle following a heart attack, in a study presented at the American College of Cardiology’s 71st Annual Scientific Session. This was the first clinical trial to test…
Read MoreChallenges persist for pediatric clinical trials
Early discontinuation and nonreporting/nonpublication of findings continue to be common issues for conducting pediatric clinical trials, according to a study published online March 22 in Pediatrics. Ryan Brewster, M.D., from the Stanford University School of Medicine in California, and colleagues…
Read MoreDeficient communication around how to access COVID-19 vaccinations could be worsening vaccine hesitancy
People who seek information on how to get a COVID-19 vaccine get widely different answers from the people who handle COVID-19 information hotlines and electronic communications, and those inconsistencies may play a role in whether someone pursues getting vaccinated, according…
Read MoreExperimental siRNA therapeutic shows promise to reduce an important driver of heart disease risk
While there are effective therapies to reduce the risk of heart disease by lowering low-density lipoprotein (LDL), or "bad" cholesterol, and other lipids, to date there are no approved treatments to lower lipoprotein(a), a lesser-known driver of heart disease risk….
Read MoreKey to detecting ovarian cancer early may be in the fallopian tubes
Tennis legend Chris Evert—known for her 18-time grand slam success in the sport—has made recent headlines after revealing an early-stage ovarian cancer diagnosis and speaking out to help others by sharing her personal experience. According to the American Cancer Society…
Read Moreathenahealth rolls out new capabilities to support transgender and nonbinary health
Mass.-based digital health company athenahealth rolled out new capabilities focused on making healthcare more inclusive for transgender and nonbinary patients. Now on its athenaOne platform, an EHR, medical billing and patient care tool, doctors can input information about a patient’s…
Read MoreExperimental heart failure drug has little impact on exercise tolerance
Heart failure patients taking the investigational drug omecamtiv mecarbil, which has been previously shown to improve long-term outcomes, see little impact on their ability to exercise compared to a placebo, according to a study supported by the Duke Clinical Research…
Read MoreSRV Hospital opens robotic orthopaedics centre with Lokmanya Hospital
SRV Hospital, a tertiary care hospital in Mumbai, together with orthopaedics specialist Lokmanya Hospital in Pune, has launched a new centre for excellence in robotic orthopaedics. According to a press statement, the SRV LHPL Centre of Excellence for Robotic Orthopaedics…
Read MoreSARS-CoV-2 prevalence during the initial period of SARS-CoV-2 Omicron variant emergence in Finland
A recent study posted to the medRxiv* preprint server presented the rapid spike in coronavirus disease 2019 (COVID-19) seroprevalence during the emergence of the Omicron variant in Finland. Study: Rapid increase in SARS-CoV-2 seroprevalence during the emergence of Omicron variant, Finland….
Read MoreMuhammad Ali: Boxing legend died from ‘extreme’ septic shock – condition explained
Frank Bruno and Piers Morgan discuss Muhammad Ali in 2016 We use your sign-up to provide content in ways you’ve consented to and to improve our understanding of you. This may include adverts from us and 3rd parties based on…
Read More